How Patients with Chronic Lymphocytic Leukemia Are Equipped to Handle the COVID-19 Pandemic

Video

Patients with chronic lymphocytic leukemia are at risk for the worst of COVID-19 symptoms, but going on the cancer journey has prepared them for the pandemic.

Treatment that weakens the immune system can often leave patients with cancer at a higher risk of illness from infections such as the new coronavirus (COVID-19). But according to Brian Koffman, the co-founder, executive vice president and chief medical officer of the CLL Society, patients with cancer, for example, those with chronic lymphocytic leukemia (CLL), may be better equipped to handle to challenges of avoiding illness thanks to their experience with cancer.

CURE® recently spoke with Koffman about how patients who are living with CLL may have to be more careful due to their immunocompromised states, but they may also be more experienced with staying safe and healthy given their treatment.

Transcription:

This will pass. We are the experts. We know how to handle a chronic illness. In some ways, it’s much easier to handle an acute illness, because many of us have been handling this for years, some of us for decades. So, we know what we have to do and what we don’t have to do.

The best course for us is to avoid getting the disease, and the guidelines are pretty clear. They’re exactly the same for us, we just have to do it better, and we just have to be extra careful about them. It’s like, you don’t have to wear two masks; you just wear a mask. You don’t have to not touch your face twice; you just don’t touch your face. So, we just have to be more careful, but we’re also more experienced at doing those things.

So, we will get through this, and there is lots of good advice out there and lots of support out there. But it’s not going to be a smooth path. I suspect that things will be bumpy. We’ll probably have resurgence of the disease in some communities, in hotspots that jump up again. We may find that we may take two steps forward and three back and we may find that it’s a bumpy road.

And I don’t think that there’s an absolute clear path yet for people like ourselves who are more vulnerable, in terms of how we’re going to be reintegrated into the community. But I think what we need to do is stay together and advocate for ourselves and for each other and be a strong community together and we will get through this.

And like I say, fewer of us (with CLL) are getting this than other people because we’re experienced in handling it. I’m optimistic that this will pass and that we’ll get through it and maybe a larger percentage of CLL patients will come out of this the other side than maybe some others.

Related Videos
Josie Montegaard, MSN, AGPCNP-BC, an expert on CLL
Yuliya P.L Linhares, MD, an expert on CLL
Jessica McDade, B.S.N., RN, OCN, in an interview with CURE
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Yuliya P.L Linhares, MD, an expert on CLL
Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL
Dr. Andrea Apolo in an interview with CURE